Use of protease inhibitors for the prevention of COVID-19.

Sagawa, Tomoya; Inoue, Ken-Ichiro; Takano, Hirohisa

Sagawa, Tomoya; Inoue, Ken-Ichiro; Takano, Hirohisa.

Afiliação

Sagawa T; Department of Environmental Engineering, Graduate School of Engineering, Kyoto University, Kyoto, Japan; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Inoue KI; School of Nursing, University of Shizuoka, Shizuoka, Japan.
Takano H; Department of Environmental Engineering, Graduate School of Engineering, Kyoto University, Kyoto, Japan; Graduate School of Global Environmental Studies, Kyoto University, Kyoto, Japan. Electronic address: takano.hirohisa.4x@kyoto-u.ac.jp.

Prev Med ; 141: 106280, 2020 12.

Article em En | MEDLINE | ID: mdl-33035549

Assuntos

COVID-19/prevenção & controle; Pandemias/prevenção & controle; Inibidores de Proteases/administração & dosagem; Adulto; Idoso; Idoso de 80 Anos ou mais; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Profilaxia Pré-Exposição; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Proteases / Pandemias / COVID-19 Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google